Senti Bio to Present at BioJapan

Core Insights - Senti Biosciences, Inc. will present at BioJapan on October 9, 2025, showcasing its innovative Gene Circuit platform for cell and gene therapies [1] - The presentation will be led by CEO Timothy Lu, and the company will also engage in one-on-one meetings with investors during the conference [1] - BioJapan is recognized as Asia's leading bio-industry partnering event, promoting collaboration and innovation in biotechnology [3] Company Overview - Senti Bio focuses on developing next-generation cell and gene therapies aimed at treating incurable diseases through its proprietary synthetic biology platform [4] - The company's Gene Circuits are engineered to selectively target and kill cancer cells while sparing healthy cells, enhancing treatment specificity and control [4] - Senti Bio's pipeline includes therapies targeting both liquid and solid tumors, with preclinical evidence supporting the efficacy of its Gene Circuits in NK and T cells [4]